Search
Cyclerion Therapeutics Inc
CYCNAdd to Watchlist
31.660USD
0.0000.00%
Market hours （ET）
148.17MMarket Cap
LossP/E TTM
CYCN Analyst Recommendation Trends
In the current month, CYCN has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CYCN average Analyst price target in the last month is 53.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
3
1
0
0
0
0
0
0
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
3
0
0
0
0
0
0
CYCN Analyst Rating for Peer Comparison
Updated: Oct 14, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
18
0
0
0
25
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
Revolution Medicines Inc
RVMD
9
14
1
0
0
24
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
7
0
0
23
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
Forecast
--
--
--
Actual
-0.21
-5.29
-2.89
Surprise
--
--
--
FAQs
What is the analyst rating for Cyclerion Therapeutics Inc?
Based on the ratings of Cyclerion Therapeutics Inc's stock from 5 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.